Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
All company news releases dating back to October 2007 refer to it as RVX-208 or more recently apabetalone. However, all clinical trials dating back to 2008 on ClinicalTrials.gov refer to the drug as RVX000222. I have no idea why the dual identity exists.
